Kontext: Echokardiografi e je v současnosti hlavní metodou pro vyšetření dysfunkce pravé komory (right ventricular dysfunction, RVD) u akutní plicní embolie (PE). Dysfunkce pravé komory je sice spojena s nepříznivou prognózou, dosud však nebyla přijata žádná obecně uznávaná defi nice. Systolický tlak v plicnici (systolic pulmonary artery pressure, sPAP) většinou není součástí kritérií RVD. Cílem naší studie bylo zhodnotit možnost použití sPAP v predikci nekrózy myokardu a RVD u akutní PE. Metody: Retrospektivně byly analyzovány údaje 182 pacientů s akutní PE. Pacienti s PE a hodnotami sPAP ≤ 30 mm Hg byli srovnáváni s pacienty s PE a hodnotami sPAP > 30 mm Hg. Vztahy mezi sPAP na jedné straně a nekrózou myokardu a RVD na straně druhé se hodnotily pomocí logistické regresní analýzy. Navíc byly vyneseny křivky ROC a vypočítány mezní hodnoty sPAP predikující nekrózu myokardu i RVD. Výsledky: Do studie bylo zařazeno 134 pacientů (průměrného věku 67,8 ± 15,2 roku; 59,7 % žen) s akutní PE příhodou. Průměrná hodnota sPAP byla 33,96 ± 18,14 mm Hg. Pacienti s PE a s hodnotou sPAP > 30 mm Hg (59,7 %) byli významně starší (71,2 ± 13,8 roku vs. 62,7 ± 15,7 roku; p = 0,000489), častěji se jednalo o ženy (66,3 % vs. 50,0 %; p = 0,0609), byly u nich naměřeny vyšší hodnoty srdeční frekvence (98,8 ± 25,5 tepu/min vs. 87,7± 22,1 tepu/min; p = 0,00266), šokového indexu (0,76 ± 0,42 vs. 0,63 ± 0,26; p = 0,00892), srdečního troponinu I (0,15 ± 0,30 ng/ml vs. 0,14 ± 0,32 ng/ml; p = 0,00670) a RVD byla u nich diagnostikována častěji (80,0 % vs. 29,6 %; p < 0,000001). V mnohorozměrném regresním modelu byly hodnoty sPAP spojeny s nekrózou myokardu (OR 1,021; 95% CI 0,998-1,045; p = 0,0736) a s RVD (OR 1,100; 95% CI 1,064-1,136, p < 0,000001). Analýza ROC pro sPAP jako prediktor nekrózy myokardu nalezla hodnotu plochy pod křivkou plazmatické koncentrace (AUC) 0,628 při mezní hodnotě sPAP 41,00 mm Hg. Analýza ROC pro sPAP jako prediktor RVD prokázala hodnotu AUC 0,829 při mezní hodnotě sPAP 31,00 mm Hg. Závěr: Hodnoty sPAP jsou spojeny s incidencí RVD i nekrózy myokardu. Systolický tlak v plicnici vysoce účinně predikoval rozvoj RVD. Hodnoty sPAP > 31 mm Hg ukazují na přítomnost RVD.
Introduction
The current European and American guidelines for acute pulmonary embolism (PE) emphasise the central role of early risk stratifi cation to identify PE patients with higher risk of early death who could benefi t from more intensive surveillance and especially more aggressive therapy [1, 2] . Rapid risk stratifi cation in acute PE is crucial in deciding appropriate therapy management [3] [4] [5] .
The mortality after an acute PE event is closely related to the initial hemodynamic status and the resulting cardiac adaptations [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . It is well known, that right ventricular dysfunction (RVD) as well as myocardial necrosis, seen as elevated cardiac Troponin (cTn) levels, both appear to alter patients' prognosis signifi cantly [2, [7] [8] [9] [10] [11] [12] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . The systolic pulmonary artery pressure (sPAP) measured in the transthoracic echocardiography is a not well established marker in the fi eld of risk stratifi cation process in acute PE. Although, there are several powerful and useful parameters of RVD to predict poorer outcome and prognosis in acute PE [29] , sPAP is a standard tool used in the follow up examinations to screen for development of pulmonary hypertension after acute PE [30] [31] [32] . There is a growing body of evidence that the intensity of sPAP increase during acute PE event seems to have an impact on the development of pulmonary hypertension after PE in long-term [33, 34] . Therefore we decided to focus this analysis on evaluation of sPAP for the early course of in-hospital stay after acute PE.
The aim of our study was to investigate the parameter of sPAP for risk stratifi cation and especially for prediction of myocardial necrosis and RVD in acute PE event.
Methods and patients
We conducted a retrospective analysis of patients with a confi rmed diagnosis of acute PE. Included patients were treated in the Internal Medicine department between May 2006 and June 2011. PE patients were identifi ed with a search in the hospital information system database for the diagnostic code of PE (ICD-Code: I26).
Studies in Germany involving the retrospective analysis of diagnostic standard data do not require an ethics statement.
Enrolled subjects
Patients were eligible for this study 1. if the diagnosis of acute PE was confi rmed by identifi ed fi lling defect in the pulmonary artery system in computed tomography pulmonary angiogram (CT) of the chest or positive venous ultrasound/ phlebography of an extremity consistent with DVT in patients with typical symptoms of PE (c hest pain or dyspnea) and a detected positive D-Dimer or scintigraphic ventilation-perfusion (V/Q) scan read as high probability for PE, 2. if sPAP was measured accurately in a transthoracic echocardiography examination, 3. if the PE patients were treated in the Internal Medicine department of the hospital, 4. and if the patients were at least 18 years old.
All CT and scintigraphic images were analyzed by experienced radiologists. If diagnosis of PE was not confi rmed by the criteria above, the patients were not included in this study.
Study parameters
The retrospectively analysis of the PE patients focused on echocardiographic examination results and cardiac biomarkers (cTnI). The sPAP was measured in the 4-chamber view in transthoracic echocardiography.
Statistics
Descriptive statistics for the relevant baseline characterization of PE patients with sPAP ≤ 30 mmHg compared to PE patients with sPAP > 30 mmHg are provided with mean and standard deviation or corresponding frequency. Continuous variables, which did not follow a normal Gaussian's distribution, were compared with the help of Wilcoxon-Whitney-U--test. Normal distributed continuous variables were compared using Students' T-test, as appropriate.
Defi nition of right ventricular dysfunction
Right ventricular dysfunction was defi ned according to the AHA scientifi c statement [2] as a quotient of right ventricular (RV) septal-lateral diameter/left ventricular (LV) septal-lateral diameter in 4-chamber view of thransthoracic echocardiography >0.9 [2] . Moreover, the RVD was defi ned as RV hypokinesis and tricuspid regurgitation in echocardiography [2] .
High-risk PE stadium
PE patients with a systolic blood pressure value of <90 mmHg at admission were classifi ed as high-risk PE according to the defi nition of the European Society of Cardiology (ESC) guidelines [1, 11] and AHA scientifi c statement [2] . We performed logistic regression models to investigate the association between sPAP in general as well as sPAP > 30 mmHg and myocardial necrosis on the one hand and RVD on the other hand. Logistic regression models were computed uni-variate fi rst. In case of signifi cance, we also calculate a multi-variate logistic regression model to test, whether the signifi cance still remains after adjustment for age and gender.
Receiver Operating Characteristic (ROC) curves with areas under the curves (AUC) and Youden Index were calculated to test the effectiveness of sPAP to predict myocardial necrosis as well as RVD in acute PE, if association was still signifi cant in the multi-variant regression model. Wilcoxon-Mann-Whitney-test was used to test the deviation of the ROC curve from the angle bisector.
Commercially available software BIAS ® (version 10.04) was used for the computerised analysis. P values of <0.05 were considered as statistically signifi cant.
Results
Between May 2006 and June 2011, 182 patients with acute confi rmed PE event were identifi ed in the hospital information system database, but only 134 of these patients met the inclusion criteria and were included in the study. The other 48 PE patients with sPAP > 30mmHg were signifi cantly older (71.2 ± 13.8 vs. 62.7 ± 15.7 years, P = 0.000489), more frequently female (66.3% vs. 50.0%, p = 0.0609) and reported more often dyspnea (92.5% vs. 75.9%, p = 0.00720). Chest pain was more frequently present in PE patients with sPAP ≤ 30 mmHg (42.6% vs. 27.5%, p = 0.071). PE patients with sPAP > 30 mmHg showed higher heart rate (98.8 ± 25.5 vs. 87.7 ± 22.1 beats/min, p = 0.00266), shock index (0.76 ± 0.42 vs. 0.63 ± 0.26, p = 0.00892), cTnI (0.15 ± 0.30 vs. 0.14 ± 0.32 ng/ml, p = 0.00670), creatinine (1.21 ± 0.46 vs. 1.03 ± 0.23 mg/dl, p = 0.0257) and D-Dimer values (3.06 ± 3.52 vs. 2.82 ± 4.48 mg/l, p = 0.0720) as well as higher percentage of RVD (80.0% vs. 29.6%, p < 0.000001). The groups did not differ signifi cantly in percentage of high-risk PE stadium and in-hospital death ( Table 1) .
The uni-variate logistic regression models showed a signifi cant association between sPAP and myocardial necrosis (OR 1.025, 95% CI 1.003-1.048, p = 0.0235) ( Table 2) as well as sPAP and RVD (OR 1.091, 95% CI 1.058-1.125, p < 0.000001) and sPAP > 30 mmHg and RVD (OR 9.500, 95% CI 4.240-21.288, p < 0.000001) ( Table 3 ). In the multivariant regression model, the association between sPAP and myocardial necrosis revealed still a borderline signifi cance independently of gender and age (OR 1.021, 95% CI 0.998-1.045, p = 0.0736) ( Table  4 ). sPAP and RVD (OR 1.100, 95% CI 1.064-1.136, p < 0.000001) ( Table 5 ) as well as sPAP > 30 mmHg and RVD (OR 10.059, 95% CI 4.239-23.870, p < 0.000001) ( Table 6) remain still signifi cantly associated after adjustment for age and gender in the multi-variant logistic regression models.
The calculated ROC analysis for sPAP predicting myocardial necrosis showed an AUC of 0.628 with sPAP cut-off value of 41.00 mmHg and a p = 0.0187 for differentiation. The percentage of misclassifi cation, sensitivity, specifi city, positive and negative predictive values were calculated as 37.2%, 60.2%, 67.3%, 75.7% and 50.0% respectively (Fig. 1) . The ROC analysis for sPAP predicting RVD revealed an AUC of 0.829 with sPAP cut-off value of 31.00 mmHg and a p < 0.000001 for differentiation. The percentage of misclassifi cation, sensitivity, specifi city, positive and negative predictive values were calculated as 24.8%, 77.9%, 73.0%, 70.4% and 80.0% respectively (Fig. 2 ).
Discussion
An acute PE involves the risk of impairment of circulation, heart and lungs [1, 10] . PE is associated with a varying degree of obstruction of the pulmonary artery bed that may lead to an increased pulmonary artery pressure [22] . If more than 30% of the pulmonary arterial bed is occluded by thrombus material, the acute PE event causes he-modynamic consequences [11] . Obstruction of blood fl ow to the lung by PE thrombus material could be followed by right heart failure with cardiac adaptations such as RVD and myocardial necrosis, cardiogenic shock and death [2, 5, 22, 35] . The right ventricle under normal conditions has a narrow range to handle an acute increase of afterload [22] . An abrupt increase of afterload, seen in cases of acute PE event, lead to elevated right ventricular wall tension that could result in right ventricular dilatation, hypokinesis and secondary tricuspid regurgitation [22] . These acute cardiac adaptations caused by acute PE event were summed up as RVD. In acute PE, presence of RVD or myocardial necrosis is associated with increased mortality [1, 2, [6] [7] [8] [9] [10] [11] [12] [13] [14] [16] [17] [18] [19] [20] [21] [22] [36] [37] [38] [39] . PE patients with an elevated cTn level showed 3.5-5.3-times increased mortality rate three months after acute PE event [7, 9, 11, 24] . Rapid risk stratifi cation in acute PE is crucial in deciding appropriate therapy management [3] [4] [5] . We investigated several different parameters for risk stratifi cation in acute PE with different issues in already published analysis using this same patient population [23, [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] . The main problem about RVD is, that there is still no generally accepted echocardiographic defi nition of RVD used for prognosis in acute PE [50] . Published studies have based their diagnosis of PE-induced RVD on a wide variable spectrum of RVD criteria [16, 18, 51] . The prognostic value of echocardiography in PE patients is reduced because of the poor standardization of echocardiographic RVD criteria [51] . Still, it remains unclear which criterion is the most sensitive indicator for patients' prognosis [18] . sPAP is in some defi nitions included in these RVD-criteria [2, 22, 50] , but in most of the studies sPAP is not part of these RVD-criteria [19, 37, 52, 53] . Therefore sPAP was also in our present analysis not included in the defi nition of RVD.
The objective of our study was to investigate sPAP as a single parameter for risk stratifi cation and especially for prediction of myocardial necrosis and RVD in acute PE event.
In accordance with the results of Pruszczyk et al., we found a mean sPAP value of brief beyond 30 mmHg (33.96 ± 18.14 mmHg) in acute PE event [50] . In contrast Park et al. reported a higher mean sPAP of 71 ± 16 mmHg in their study sample of patients with acute PE [54] . Nearly 60% of our PE patients showed a sPAP of more than 30 mmHg. Ribeiro et al. reported a higher percentage of 92.3% of their included PE patients [22] .
In our present analysis PE patients with higher sPAP were older, had higher cTnI values and more often RVD in echocardiography. sPAP was strongly associated with myocardial necrosis and RVD. An increase of sPAP within 1 mmHg leads to an increase of the risk for myocardial necrosis of 2.1% and of the risk of presence of RVD of 10.1%.
The effectiveness of sPAP to predict myocardial necrosis with cut-off value of 41.00 mmHg was moderate (AUC 0.628), while that of sPAP predicting RVD with cut-off value of 31.00 mmHg was excellent (AUC 0.829).
Pruszczyk et al. reported a signifi cant higher sPAP value in PE patients, who died or needed a thrombolysis, than in those without both [50] . The study of Ribeiro et al. failed briefl y to reveal a signifi cant higher percentage of mortality in patients with sPAP > 30 mmHg than in those with ≤ 30 mmHg [22] . Five-year survival was in the The prognostic value of echocardiography examination for risk stratifi cation in acute PE was confi rmed in several studies [16] [17] [18] [19] [20] 37, 51] . Echocardiography is currently the mainstay examination for assessment of RVD in acute PE [18] . In various studies, RVD was connected with higher rates of death, recurrent PE events and complications [2, 11, [16] [17] [18] [19] [20] .
Although, transthoracic echocardiography with sPAP is used as a standard screening method to detect pulmonary hypertension after PE in follow-up examinations, results about accuracy of this method are inconsistent [30] [31] [32] . While some studies revealed a high accuracy [32] , other studies reported limitations in accuracy of echocardiography in hemodynamic assessment of pulmonary hypertension [30, 31] . Lafi tte et al. found a strong correlation between Doppler sPAP values and measurements in right heart catheterization [32] . In contrast, Fisher et al. reported, that the Doppler echocardiography is frequently inaccurate in estimating sPAP in comparison to the results of the invasive measurements in patients being evaluated for pulmonary embolism [30] .
Furthermore, it is important to be aware that sPAP is dependent on age and body mass index [31] . Age related increases in sPAP are more prevalent in patients with diabetes [31] . Beside all these limitations, higher sPAP was connected with an increased mortality [31] . In addition, studies have emphasized that the intensity of sPAP elevation at acute PE event had an impact on the development of pulmonary hypertension in long-term [33, 34] .
The results of our study reveal that sPAP as a single parameter for risk stratifi cation is not powerful enough, but the strong association between sPAP and RVD is a good argument to include sPAP as a further criterion to RVD criteria. sPAP as a single parameter for risk stratifi cation may be useful in patients without preexisting sPAP elevation, but preexisting pulmonary hypertension could preexist especially in patients with chronic lung diseases and valve disorders and mostly this sPAP elevation is not known [56, 57] . The sPAP cut-off value of 31 mmHg to predict RVD suggests that the afterload criterion of sPAP 30 mmHg may be a good cut-off to differentiate between PE patients with and those without RVD.
Limitations
Important study limitations are the small number of included PE patients, the single center study design and the retrospective study character. Moreover, we assessed the sPAP only in the acute phase of the PE event and we did not know how high the sPAP was before PE event. Several diseases, especially chronic lung diseases and heart valve diseases, could lead to a pulmonary hypertension. Therefore, we have to suggest a bias in this point.
Conclusions
sPAP and RVD as well as sPAP and myocardial necrosis are both associated. sPAP is effective to predict RVD in acute PE. sPAP values > 31 mmHg indicate for RVD.
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